Coenzyme Q10 soft capsules

1. Improvement of the utilization rate of ischemic myocardium. This product can improve the decrease in contractility and shortened duration of active potential caused by oxygen perfusion (Tyrode perfusion method) of woodchuck ventricular muscle. 2. Activation of myocardial mitochondrial ATP synthesis. According to the experiments on dogs, this product can improve the respiratory regulation rate (RCI) of myocardial mitochondria and the low ATP synthesis rate under ischemic conditions. In addition, in the perfusion experiments of rabbits and rats, this agent can not only resist the decrease in ATP synthesis accompanied by ischemia and reperfusion, but also promote ATP synthesis. 3. Improvement of low cardiac function Experiments on rats show that this product can inhibit the decrease in myocardial contractility caused by ischemia and reperfusion, and improve low myocardial function. 4. Myocardial protection This product has antioxidant and cell membrane stabilizing effects, which can be proved from the rat experiment that this agent can resist the cardiac disorders caused by doxorubicin hydrochloride, and in the ischemic experiment of dogs, it is proved that this product can inhibit the release of myocardial enzymes into the blood. 5. Anti-aldosterone effect In the experiment on rats, this agent can not only inhibit the secretion of aldosterone, but also antagonize the Na retention caused by aldosterone, promote the diuretic effect of Na, but does not affect the excretion of K.

The main ingredient of this product is coenzyme Q10, whose chemical name is 2,3-dimethoxy-5-methyl-6-{poly-[2-methylbutene(2)yl}-benzoquinone.

This product is a soft capsule containing an orange-yellow oily solution.

Used as an auxiliary treatment for acute and chronic hepatitis, mild to moderate congestive heart failure and cancer.

Oral administration: Adults take 1 tablet each time, 3 times a day, after meals.

After taking this product, skin rash, stomach discomfort, loss of appetite, nausea, diarrhea, etc. may occasionally occur.

It is contraindicated for those who are allergic to this product.

Precautions for children: This experiment has not been conducted and there are no reliable references. Precautions for pregnancy and lactation: Female rats were orally administered this product at a dose of 10mg, 100mg and 1000mg/Kg per day from before conception to the early stage of conception. The results showed that it had no effect on conception and implantation, and there was no inhibition or teratogenicity on the development of the fetus. During the period of organ formation, 10mg, 100mg and 1000mg/Kg were administered daily. The results showed that there were no abnormalities in the mother, fetus and newborn, and no teratogenicity was observed. During the perinatal and lactation period of female rats, 10mg, 100mg and 1000mg/Kg were administered daily. The results showed that there was no effect on the morphology, development, function, reproductive ability of the mother and newborn, and the fetus. Precautions for the elderly: This experiment has not been conducted and there are no reliable references.

Not yet clear

Protect from light, seal tightly, and store in a cool and dry place.

10mg

24 months

Zhejiang Qianyuan Haili Sheng Pharmaceutical Co., Ltd.

• Founded in:

  1990-06-04

• Address:

  No. 66, Xingang 11th Road, Xingang Park, Zhoushan Economic Development Zone, Zhejiang Province

• Tax NO.:

  91330900148699778M

• Registered Funds:

  20 million yuan

• Website:

  Log in to view

• Email:

  Log in to view